BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11106358)

  • 1. Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.
    Hes FJ; McKee S; Taphoorn MJ; Rehal P; van Der Luijt RB; McMahon R; van Der Smagt JJ; Dow D; Zewald RA; Whittaker J; Lips CJ; MacDonald F; Pearson PL; Maher ER
    J Med Genet; 2000 Dec; 37(12):939-43. PubMed ID: 11106358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.
    Furness H; Salfity L; Devereux J; Halliday D; Hanson H; Ruddy DM; Uk Vhl Study Group ; Shah N; Sultana G; Woodward ER; Sandford RN; Snape KM; Maher ER
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VHL mutation analysis in patients with isolated central nervous system haemangioblastoma.
    Woodward ER; Wall K; Forsyth J; Macdonald F; Maher ER
    Brain; 2007 Mar; 130(Pt 3):836-42. PubMed ID: 17264095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low frequency of VHL germline mutations in Norwegian patients presenting with isolated central nervous system hemangioblastomas--a population-based study.
    Rønning P; Andresen PA; Hald JK; Heimdal K; Scheie D; Schreiner T; Helseth E
    Acta Neurol Scand; 2010 Aug; 122(2):124-31. PubMed ID: 19814753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic register for von Hippel-Lindau disease.
    Maddock IR; Moran A; Maher ER; Teare MD; Norman A; Payne SJ; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans DG
    J Med Genet; 1996 Feb; 33(2):120-7. PubMed ID: 8929948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
    Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
    J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
    Richard S; Martin S; David P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
    Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
    Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
    Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
    Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
    Catapano D; Muscarella LA; Guarnieri V; Zelante L; D'Angelo VA; D'Agruma L
    Neurosurgery; 2005 Jun; 56(6):1215-21; discussion 1221. PubMed ID: 15918937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
    Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
    Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
    Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
    J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.
    Mathó C; Sansó G; Diez B; Barontini M; Pennisi PA
    Genet Test Mol Biomarkers; 2016 Dec; 20(12):771-776. PubMed ID: 27617348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
    Webster AR; Maher ER; Moore AT
    Arch Ophthalmol; 1999 Mar; 117(3):371-8. PubMed ID: 10088816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations in the new E1' cryptic exon of the
    Buffet A; Calsina B; Flores S; Giraud S; Lenglet M; Romanet P; Deflorenne E; Aller J; Bourdeau I; Bressac-de Paillerets B; Calatayud M; Dehais C; De Mones Del Pujol E; Elenkova A; Herman P; Kamenický P; Lejeune S; Sadoul JL; Barlier A; Richard S; Favier J; Burnichon N; Gardie B; Dahia PL; Robledo M; Gimenez-Roqueplo AP
    J Med Genet; 2020 Nov; 57(11):752-759. PubMed ID: 31996412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group.
    Richard S; Campello C; Taillandier L; Parker F; Resche F
    J Intern Med; 1998 Jun; 243(6):547-53. PubMed ID: 9681857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
    Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
    J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.